Dong Hoon Lee1, Ji Eun Park1, Duck Mi Yoon1, Kyung Bong Yoon1, Kiwook Kim1, Shin Hyung Kim2. 1. Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea. 2. Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea tessar@yuhs.ac.
Abstract
OBJECTIVE: To determine the risk factors associated with clinical insomnia in postherpetic neuralgia (PHN) patients. DESIGN: A retrospective cross-sectional study. SETTING: Outpatient department for interventional pain management at a university hospital. SUBJECTS: A total of 111 patients with PHN satisfied the study inclusion criteria and were included in the analyses. METHODS: The Insomnia Severity Index (ISI) was used to determine the presence of clinical insomnia (ISI score ≥ 15). Patient demographics, pain-related factors, and rash severity and location were evaluated with logistic regression analysis to identify risk factors of clinical insomnia among patients with PHN. RESULTS: In total, 50.5% of patients reported mild to severe insomnia symptoms (ISI score ≥ 8) after pain development. Moderate to severe clinical insomnia (ISI score ≥ 15) was observed in 30.6% of PHN patients. Multivariate logistic regression analyses revealed that high pain intensity was the strongest predictor of clinical insomnia (odds ratio (OR) = 12.417, 95% confidence interval (CI): 2.990-51.561, P = 0.001). However, presence of mechanical allodynia (OR = 4.263, 95% CI: 1.040-17.481, P = 0.034) and high anxiety and depression level (OR = 4.452, 95% CI: 1.201-16.508, P = 0.026; OR = 6.975, 95% CI: 1.425-34.138, P = 0.017) were also significantly associated with clinical insomnia after adjusting for pain score. Clinical insomnia was not significantly related to age, gender, rash severity, or location of skin lesion. CONCLUSIONS: Insomnia should be addressed as an important part of pain management in PHN patients with these risk factors, especially in patients with severe pain.
OBJECTIVE: To determine the risk factors associated with clinical insomnia in postherpetic neuralgia (PHN) patients. DESIGN: A retrospective cross-sectional study. SETTING:Outpatient department for interventional pain management at a university hospital. SUBJECTS: A total of 111 patients with PHN satisfied the study inclusion criteria and were included in the analyses. METHODS: The Insomnia Severity Index (ISI) was used to determine the presence of clinical insomnia (ISI score ≥ 15). Patient demographics, pain-related factors, and rash severity and location were evaluated with logistic regression analysis to identify risk factors of clinical insomnia among patients with PHN. RESULTS: In total, 50.5% of patients reported mild to severe insomnia symptoms (ISI score ≥ 8) after pain development. Moderate to severe clinical insomnia (ISI score ≥ 15) was observed in 30.6% of PHNpatients. Multivariate logistic regression analyses revealed that high pain intensity was the strongest predictor of clinical insomnia (odds ratio (OR) = 12.417, 95% confidence interval (CI): 2.990-51.561, P = 0.001). However, presence of mechanical allodynia (OR = 4.263, 95% CI: 1.040-17.481, P = 0.034) and high anxiety and depression level (OR = 4.452, 95% CI: 1.201-16.508, P = 0.026; OR = 6.975, 95% CI: 1.425-34.138, P = 0.017) were also significantly associated with clinical insomnia after adjusting for pain score. Clinical insomnia was not significantly related to age, gender, rash severity, or location of skin lesion. CONCLUSIONS:Insomnia should be addressed as an important part of pain management in PHNpatients with these risk factors, especially in patients with severe pain.
Authors: Sheng-Yuan Yu; Bi-Fa Fan; Fei Yang; Marco DiBonaventura; Yu-Xuan Chen; Ruo-Yu Li; Kristen King-Concialdi; Ian Kudel; Patrick Hlavacek; Markay Hopps; Margarita Udall; Alesia Sadosky; Joseph C Cappelleri Journal: Clinicoecon Outcomes Res Date: 2019-09-03
Authors: Lidia Santiago Guandalini; Eduarda Ferreira da Silva; Juliana de Lima Lopes; Vinicius Batista Santos; Camila Takao Lopes; Alba Lúcia Bottura Leite de Barros Journal: Int J Nurs Sci Date: 2020-09-13